Fp receptor antagonists or pgf2 alpha antagonists for treating pathological conditions of the uterus

Fp receptor antagonists or pgf2 alpha antagonists for treating pathological conditions of the uterus

A method of treating or preventing a pathological condition of the uterus in an female individual, the method comprising administering to the individual at least one agent that prevents PGF2alpha, having its effect on the FP receptor. Typically, the pathological condition is uterine cancer, fibroids...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CRITCHLEY HILARY O.D, JABBOUR HENRY N, MILNE STUART A
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A method of treating or preventing a pathological condition of the uterus in an female individual, the method comprising administering to the individual at least one agent that prevents PGF2alpha, having its effect on the FP receptor. Typically, the pathological condition is uterine cancer, fibroids or endometriosis.